AU1874500A - 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders - Google Patents
1,4-diazacycloheptane derivatives useful in the treatment of neurological disordersInfo
- Publication number
- AU1874500A AU1874500A AU18745/00A AU1874500A AU1874500A AU 1874500 A AU1874500 A AU 1874500A AU 18745/00 A AU18745/00 A AU 18745/00A AU 1874500 A AU1874500 A AU 1874500A AU 1874500 A AU1874500 A AU 1874500A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- neurological disorders
- derivatives useful
- diazacycloheptane derivatives
- diazacycloheptane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828436.7A GB9828436D0 (en) | 1998-12-24 | 1998-12-24 | Chemical compounds |
| GB9828436 | 1998-12-24 | ||
| GBGB9914015.4A GB9914015D0 (en) | 1999-06-17 | 1999-06-17 | Chemical compounds |
| GB9914015 | 1999-06-17 | ||
| PCT/GB1999/004329 WO2000039105A1 (en) | 1998-12-24 | 1999-12-20 | 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1874500A true AU1874500A (en) | 2000-07-31 |
Family
ID=26314903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18745/00A Abandoned AU1874500A (en) | 1998-12-24 | 1999-12-20 | 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1140863A1 (en) |
| JP (1) | JP2002533447A (en) |
| AU (1) | AU1874500A (en) |
| GB (1) | GB9930014D0 (en) |
| WO (1) | WO2000039105A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9914026D0 (en) * | 1999-06-17 | 1999-08-18 | Zeneca Ltd | Chemical compounds |
| JP5932636B2 (en) | 2009-05-05 | 2016-06-08 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド | Therapeutic compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1335591C (en) * | 1988-05-23 | 1995-05-16 | James Arthur Nixon | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
| US5807897A (en) * | 1996-03-01 | 1998-09-15 | Zeneca Limited | Aminotetralin derivative and compositions and method of use thereof |
| AU717431B2 (en) * | 1996-07-01 | 2000-03-23 | Schering Corporation | Muscarinic antagonists |
| GB9726736D0 (en) * | 1997-12-18 | 1998-02-18 | Zeneca Ltd | Chemical compounds |
-
1999
- 1999-12-20 EP EP99962379A patent/EP1140863A1/en not_active Withdrawn
- 1999-12-20 AU AU18745/00A patent/AU1874500A/en not_active Abandoned
- 1999-12-20 WO PCT/GB1999/004329 patent/WO2000039105A1/en not_active Application Discontinuation
- 1999-12-20 JP JP2000591016A patent/JP2002533447A/en active Pending
- 1999-12-21 GB GBGB9930014.7A patent/GB9930014D0/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB9930014D0 (en) | 2000-02-09 |
| EP1140863A1 (en) | 2001-10-10 |
| JP2002533447A (en) | 2002-10-08 |
| WO2000039105A1 (en) | 2000-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100069A3 (en) | 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders | |
| HUP0100779A3 (en) | Novel derivatives of 3,3-diphenylpropylamines | |
| PL338013A1 (en) | Derivatives of condensed 1,2,4-thiadiazine, their production and application | |
| AU6462500A (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| AU4060599A (en) | Pharmaceutical composition for treating or preventing sleep disorders | |
| IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| PL338637A1 (en) | Heterocyclic vinyl ethers efefctive as agents against neurological disorders | |
| NZ330988A (en) | 5h-thiazolo[3,2-a]pyrimidine derivatives used as neurological medicaments | |
| AU1450900A (en) | Methods of treatment of type 2 diabetes | |
| AU2396000A (en) | Treatment of hyperproliferative disorders using casein kinase | |
| AU6910600A (en) | Methods for the treatment of mental disorders | |
| AU2058697A (en) | Treatment of sleep disorders | |
| IL137518A0 (en) | Derivatives of 1,2,4-oxadiazolone | |
| AU5160599A (en) | Method for the production of n,n'-carbonyl diazoles | |
| AU5414100A (en) | Chroman derivatives against neurological disorders | |
| CZ20011872A3 (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
| AU1874500A (en) | 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders | |
| IL136949A0 (en) | 1,4-diazacycloheptane derivatives for the treatment of neurological disorders | |
| AU6581294A (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
| AU6870500A (en) | Process for the preparation of 2,3-dihydroazepine derivatives | |
| AU3962999A (en) | The method of microobjects' study | |
| AU9285298A (en) | Smokers' article | |
| AU3060500A (en) | 1,4-diazacycloheptane compounds, process for their preparation, and their use asmedicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |